arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

BGM Group Ltd.

BGM
$8.85 ▲ +0.04 (+0.45%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
7 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

BGM Group Ltd. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0B
Dividend Yield —
Revenue Growth 51.1% ↗
Op. Margin -33.2% ↘
ROIC -3.3% ↘
FCF / Share $-0.03 ↘
Trailing P/E —
Price / Book 4.5x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$37.92M
↑ +51.1% —
Net Income Profit after all expenses
$-19.94M
↓ -1282.1% —
Operating Margin Operating profit as % of sales
-33.2%
↓ -1377.1% 7th
FCF / Share Free cash flow per share
$-0.03
↓ -182.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
8
Returns
38
Financial Health
8
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 7 quarters